Tumor necrosis factor alpha and colitis-associated colon cancer.
Wilson
Joanne A P
JA
Department of Gastroenterology, Duke University Medical Center, Durham, NC, USA.
D000818:Animals; D001397:Azoxymethane; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000150:complications*; D003110:Colonic Neoplasms / Q000209:etiology / Q000517:prevention & control*; D016264:Dextran Sulfate; D004195:Disease Models, Animal; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D051379:Mice; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D016264:Dextran Sulfate; D001397:Azoxymethane; D000068800:Etanercept